Skip to content
healthcare.dev

Methocarbamol

NDC 87063-689, methocarbamol, tablet, from ASCLEMED USA INC..

Product NDC
87063-689
Status
Listed
Labeler
ASCLEMED USA INC.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA040489
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/87063-689 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • METHOCARBAMOL750 mg/1

Pharmacologic classes

Centrally-mediated Muscle Relaxation [PE]; Muscle Relaxant [EPC]

Package NDCNDC-11Package
87063-689-1287063068912120 TABLET in 1 BOTTLE (87063-689-12)
87063-689-308706306893030 TABLET in 1 BOTTLE (87063-689-30)
87063-689-608706306896060 TABLET in 1 BOTTLE (87063-689-60)
87063-689-908706306899090 TABLET in 1 BOTTLE (87063-689-90)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 87063-689 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/87063-689 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 87063-689. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.